Open Access · CC BY-NC 3.0
First-line therapy of chronic myeloid leukemia – focus on dasatinib
Blood and Lymphatic Cancer: Targets and Therapy · 2012
DOI: 10.2147/blctt.s17930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2012. Verfasst von Philip Amrein. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Amrein, P. (2012). First-line therapy of chronic myeloid leukemia – focus on dasatinib. Blood and Lymphatic Cancer: Targets and Therapy. https://doi.org/10.2147/blctt.s17930
Vancouver
Amrein P. First-line therapy of chronic myeloid leukemia – focus on dasatinib. Blood and Lymphatic Cancer: Targets and Therapy. 2012. doi:10.2147/blctt.s17930
BibTeX
@article{Amrein2012,
author = {Amrein, Philip},
title = {First-line therapy of chronic myeloid leukemia – focus on dasatinib},
journal = {Blood and Lymphatic Cancer: Targets and Therapy},
year = {2012},
doi = {10.2147/blctt.s17930}
}
EUVIMED